van Asperen CJ - Search Results

1

Exploring the short-term impact of DNA-testing in breast cancer patients: the counselees' perception matters, but the actual BRCA1/2 result does not.

Vos J, Oosterwijk JC, Gomez-Garcia E, Menko FH, Collee MJ, van Asperen CJ, Jansen AM, Stiggelbout AM, Tibben A. Vos J, et al. Among authors: van asperen cj. Patient Educ Couns. 2012 Feb;86(2):239-51. doi: 10.1016/j.pec.2011.04.017. Epub 2011 Dec 27. Patient Educ Couns. 2012. PMID: 21684708

2

The CHEK2*1100delC variant acts as a breast cancer risk modifier in non-BRCA1/BRCA2 multiple-case families.

Oldenburg RA, Kroeze-Jansema K, Kraan J, Morreau H, Klijn JG, Hoogerbrugge N, Ligtenberg MJ, van Asperen CJ, Vasen HF, Meijers C, Meijers-Heijboer H, de Bock TH, Cornelisse CJ, Devilee P. Oldenburg RA, et al. Among authors: van asperen cj. Cancer Res. 2003 Dec 1;63(23):8153-7. Cancer Res. 2003. PMID: 14678969

3

Risk estimation for healthy women from breast cancer families: new insights and new strategies.

van Asperen CJ, Jonker MA, Jacobi CE, van Diemen-Homan JE, Bakker E, Breuning MH, van Houwelingen JC, de Bock GH. van Asperen CJ, et al. Among authors: van diemen homan je, van houwelingen jc. Cancer Epidemiol Biomarkers Prev. 2004 Jan;13(1):87-93. doi: 10.1158/1055-9965.epi-03-0090. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 14744738

4

Feeling at risk: how women interpret their familial breast cancer risk.

van Dijk S, Otten W, van Asperen CJ, Timmermans DR, Tibben A, Zoeteweij MW, Silberg S, Breuning MH, Kievit J. van Dijk S, et al. Among authors: van asperen cj. Am J Med Genet A. 2004 Nov 15;131(1):42-9. doi: 10.1002/ajmg.a.30322. Am J Med Genet A. 2004. PMID: 15382029

5

Variants of uncertain clinical significance as a result of BRCA1/2 testing: impact of an ambiguous breast cancer risk message.

van Dijk S, van Asperen CJ, Jacobi CE, Vink GR, Tibben A, Breuning MH, Otten W. van Dijk S, et al. Among authors: van asperen cj. Genet Test. 2004 Fall;8(3):235-9. doi: 10.1089/gte.2004.8.235. Genet Test. 2004. PMID: 15727245

6

What's the message? Interpretation of an uninformative BRCA1/2 test result for women at risk of familial breast cancer.

van Dijk S, Otten W, Timmermans DR, van Asperen CJ, Meijers-Heijboer H, Tibben A, Breuning MH, Kievit J. van Dijk S, et al. Among authors: van asperen cj. Genet Med. 2005 Apr;7(4):239-45. doi: 10.1097/01.gim.0000159902.34833.26. Genet Med. 2005. PMID: 15834241 Free article.

7

Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.

van Oostrom I, Meijers-Heijboer H, Duivenvoorden HJ, Bröcker-Vriends AH, van Asperen CJ, Sijmons RH, Seynaeve C, Van Gool AR, Klijn JG, Tibben A. van Oostrom I, et al. Among authors: van asperen cj, van gool ar. Patient Educ Couns. 2007 Jan;65(1):58-68. doi: 10.1016/j.pec.2006.05.006. Epub 2006 Jul 26. Patient Educ Couns. 2007. PMID: 16872788

8

Clinical characteristics affect the impact of an uninformative DNA test result: the course of worry and distress experienced by women who apply for genetic testing for breast cancer.

van Dijk S, Timmermans DR, Meijers-Heijboer H, Tibben A, van Asperen CJ, Otten W. van Dijk S, et al. Among authors: van asperen cj. J Clin Oncol. 2006 Aug 1;24(22):3672-7. doi: 10.1200/JCO.2005.03.7259. J Clin Oncol. 2006. PMID: 16877736

9

A prospective study of the impact of genetic susceptibility testing for BRCA1/2 or HNPCC on family relationships.

van Oostrom I, Meijers-Heijboer H, Duivenvoorden HJ, Bröcker-Vriends AH, van Asperen CJ, Sijmons RH, Seynaeve C, Van Gool AR, Klijn JG, Riedijk SR, van Dooren S, Tibben A. van Oostrom I, et al. Among authors: van asperen cj, van dooren s, van gool ar. Psychooncology. 2007 Apr;16(4):320-8. doi: 10.1002/pon.1062. Psychooncology. 2007. PMID: 16909428

10

Prognostic factors for hereditary cancer distress six months after BRCA1/2 or HNPCC genetic susceptibility testing.

van Oostrom I, Meijers-Heijboer H, Duivenvoorden HJ, Bröcker-Vriends AH, van Asperen CJ, Sijmons RH, Seynaeve C, Van Gool AR, Klijn JG, Tibben A. van Oostrom I, et al. Among authors: van asperen cj, van gool ar. Eur J Cancer. 2007 Jan;43(1):71-7. doi: 10.1016/j.ejca.2006.08.023. Epub 2006 Oct 11. Eur J Cancer. 2007. PMID: 17045473

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

219 results

Search Page